ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 147 filers reported holding ITEOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,860,662 | -15.4% | 1,813,759 | +2.3% | 0.00% | -100.0% |
| Q2 2023 | $23,479,181 | -2.7% | 1,773,352 | +0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,130,380 | -32.1% | 1,772,989 | -2.5% | 0.00% | 0.0% |
| Q4 2022 | $35,525,655 | +6.5% | 1,819,030 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $33,358,000 | -0.6% | 1,751,100 | +7.5% | 0.00% | 0.0% |
| Q2 2022 | $33,569,000 | -29.3% | 1,629,586 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $47,499,000 | -3.8% | 1,476,042 | +39.1% | 0.00% | 0.0% |
| Q4 2021 | $49,392,000 | +195.5% | 1,060,810 | +71.4% | 0.00% | – |
| Q3 2021 | $16,714,000 | +26.5% | 619,031 | +20.2% | 0.00% | – |
| Q2 2021 | $13,209,000 | -44.3% | 514,975 | -25.8% | 0.00% | -100.0% |
| Q1 2021 | $23,711,000 | +7.6% | 693,751 | +6.4% | 0.00% | 0.0% |
| Q4 2020 | $22,043,000 | +109.6% | 651,778 | +52.9% | 0.00% | – |
| Q3 2020 | $10,517,000 | – | 426,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |